These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5428166)

  • 1. [On the nephrotoxicity of cephaloridine: deductions from clinical use of the substance].
    Verzetti G; Pagano G; Busilacchi M; Perpignano G; Cirillo R
    Minerva Med; 1970 Jun; 61(50):2779-86. PubMed ID: 5428166
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of a new antibiotic: cephaloridine].
    De Petra V
    Clin Ter; 1967 Jul; 42(2):147-62. PubMed ID: 5596413
    [No Abstract]   [Full Text] [Related]  

  • 3. [Considerations on the use of cephaloridine in human pathology].
    Dioguardi N; Idéo G
    Minerva Med; 1966 Jun; 57(47):2161-75. PubMed ID: 5939915
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nephrotoxicity of gentamycin used in hepatic and biliary diseases].
    Debska-Slizień A; Rutkowski B
    Pol Tyg Lek; 1991 Feb 18-Mar 4; 46(8-10):169-71. PubMed ID: 1845739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical trial of phloroglucinol-trimethyl ether in the treatment of biliary and intestinal diseases].
    Mainguet P
    Brux Med; 1968 Jun; 48(6):383-6. PubMed ID: 5680620
    [No Abstract]   [Full Text] [Related]  

  • 6. Cephaloridine therapy in patients with surgical infections.
    Dillon ML; Bowling KA; Postlethwait RW
    Surg Gynecol Obstet; 1972 Jan; 134(1):83-8. PubMed ID: 5007179
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experiences with a new selective antispastic derivative of anisotropine].
    Vignola D; Galvani A
    Clin Ter; 1968 Oct; 47(2):175-85. PubMed ID: 5755355
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experiences with a new tetracycline (6-methylene-5-hydroxytetracycline or Methacycline)].
    Anselmi E; Nisii M
    Minerva Med; 1966 Nov; 57(91):3840-5. PubMed ID: 5957797
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical observations on the effect of a synthetic product with spasmolytic action, on abdominal pain manifestations].
    Ciravegna G; Michetti P; De Conca V
    Clin Ter; 1971 May; 57(3):227-36. PubMed ID: 5110943
    [No Abstract]   [Full Text] [Related]  

  • 10. Antalgic properties of proxazole. Double blind study in visceral algoplastic conditions.
    De Gregorio M; Damiani S; Gatta G
    Panminerva Med; 1969 Sep; 11(9):436-40. PubMed ID: 4901029
    [No Abstract]   [Full Text] [Related]  

  • 11. A multicentre dose-response trial with cephaloridine.
    Foord RD
    Postgrad Med J; 1967 Aug; 43():Suppl 43:63-9. PubMed ID: 4861120
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experimentation with pentanobornamide, a new synthetic spasmolytic].
    Miracco A; Peluso C
    Clin Ter; 1970 Mar; 52(6):557-63. PubMed ID: 4916457
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological and clinical aspects of the use of a new choleretic, 1-morpholinoacetyl-3-phenyl-4-oxo-1,2,3,4-tetrahydroquinazoline hydrochloride].
    Grossi F; Spada S
    Clin Ter; 1969 Aug; 50(3):203-32. PubMed ID: 5387397
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study of N-(pyrrolidine-methyl) tetracycline in "rapid" intravenous administration].
    Ruberti A; Tobaldin G; Mirizio A
    Minerva Med; 1968 Sep; 59(76):3983-4001. PubMed ID: 5698740
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the radio-clinical effects of a new preparation with bilio-digestive action. (Pharmacological association of metoclopramide and dihydroxybutyl ether].
    Cosmacini G
    Minerva Gastroenterol; 1968; 14(4):274-84. PubMed ID: 5745808
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepadigest (UR-232) clinical experimentation].
    Pasqual Mostaza A
    Rev Esp Enferm Apar Dig; 1972 Dec; 38(7):869-80. PubMed ID: 4641559
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experience with a new analgesic and antispastic combination].
    Mascheroni VC
    Clin Ter; 1970 Aug; 54(3):261-6. PubMed ID: 5491283
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal damage associated with prolonged administration of ampicillin, cephaloridine, and cephalothin.
    Benner EJ
    Antimicrob Agents Chemother (Bethesda); 1969; 9():417-20. PubMed ID: 5396519
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trial of a new analgesic and antispastic drug combination].
    Mariani L; Pinto E
    Clin Ter; 1975 Feb; 72(3):255-73. PubMed ID: 48445
    [No Abstract]   [Full Text] [Related]  

  • 20. Absence of nephrotoxicity during cephaloridine therapy.
    McAllister TA
    Lancet; 1972 Sep; 2(7779):710. PubMed ID: 4115843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.